Agathe Richard is counsel in the Litigation Department of Willkie Farr & Gallagher LLP in New York. Agathe’s focus includes U.S. antitrust law and European competition law (merger control notifications with an emphasis on analysis and compliance under the Hart-Scott-Rodino Act, merger investigations, restrictive arrangements and monopolization cases).


  • “A Holistic Assessment of Dynamic Competition”, Concurrences Review (2016) (co-authored)
  • “In-House Practice For International Antitrust Investigation” (Lawline, 2014) (co-authored)
  • “Reverse Payment Settlements in the United States and Europe: Moving Toward An Effects-Based Approach”, CPI Antitrust Chronicle (September 2013) (co-authored)

Agathe advised on the following significant matters:

Merger Counseling

  • Centerbridge/Davis Vision
  • Interpublic Group/Acxiom Marketing Solutions
  • W&W/AFCO Steel Corporation / Hirschfeld Industries
  • BB&T/Swett & Crawford
  • Constantia/Multi -Color Corporation
  • Dormakaba/Stanley Black and Decker
  • Tornier/ Wright Medical Group (approval following second request and consensual divestitures with FTC)
  • Men’s Wearhouse/Jos. A. Bank (unconditional approval following second request by FTC)
  • Teva Pharmaceuticals/Cephalon (Phase I with conditions, European Commission)
  • Teva Pharmaceuticals/Ratiopharm (Phase I with conditions, European Commission)
  • Gaz de France/Suez (Phase II with conditions, European Commission)

Investigations and Litigations

  • Teva Pharmaceuticals in the Perindopril and Modafinil antitrust investigations by the European Commission
  • High tech investigations in Europe, the United States, and Canada



Fordham University School of Law, LL.M., 2013 Université Paris II - Panthéon-Assas, DESS, 2005 HEC, Master, 2004 Université Paris I - Panthéon-Sorbonne, DESS, 2004

Bar Admissions

New York, 2014 Paris, 2006